BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Huonslab Secures Patent for ADC Subcutaneous Formulation Incorporating ‘HyDIFFUZE™’ Platform

  July 27, 2026

   · 

  2 min read
• 

  C-suite

  Sarepta names former AbbVie R&D exec Michael Severino as next CEO

  After leaving Tessera Therapeutics earlier this month, Michael Severino will take over Sarepta Therapeutics as the biotech awaits two key regulatory decisions in Duchenne muscular dystrophy.

  July 27, 2026

   · 

  3 min read

   · 

  Annalee Armstrong
• Press Releases

  Applied Biologics Announces Extension of Longstanding System-Wide Agreement With Providence Health & Services for XWRAP®

  July 27, 2026

   · 

  3 min read
• Press Releases

  Advita Ortho Acquires Bauer Innovations’ Patent Applications for Unique Shoulder Arthroplasty Technologies, Strengthening Advita’s Expanding Shoulder Portfolio

  July 27, 2026

   · 

  2 min read
• Press Releases

  LAPIX Therapeutics Appoints Nimbus CEO Abbas Kazimi to Board of Directors

  July 27, 2026

   · 

  2 min read
• Press Releases

  Massive Bio and GELL Announce Strategic Partnership to Advance Research, Medical Education, and Artificial Intelligence Across Latin America and the United States

  July 27, 2026

   · 

  5 min read
• Press Releases

  Feinstein Institutes Unveils World’s First Comprehensive Vagus Nerve Map, Substantiating Decades of Leadership in Bioelectronic Medicine

  July 27, 2026

   · 

  5 min read
• 

  Business

  Gossamer regains rights to lung disease asset from Chiesi after Phase 3 fail

  Despite a Phase 3 miss, Gossamer Bio is full steam ahead for its lung disease asset, pointing to previous “review issues” at the FDA as one of the reasons to continue development.

  July 27, 2026

   · 

  3 min read

   · 

  Gabrielle Masson
• Press Releases

  Vivos Inc. (OTCQB: RDGL) Reports Second Quarter 2026 Progress and Corporate Update - Correction

  July 27, 2026

   · 

  6 min read
• Press Releases

  Neuvotion Announces Commercialization of Brain-Computer Interface and Brain-Body Interface Technologies – Related Clinical Study Published in Nature Medicine

  July 27, 2026

   · 

  4 min read